Evidence map›Paper›PMID 32274426›Full record

ArticleClinical and translational radiation oncology2020

Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation.

José Marcio Luna, Hann-Hsiang Chao, Russel T Shinohara, Lyle H Ungar, Keith A Cengel, Daniel A Pryma, Chidambaram Chinniah, Abigail T Berman, Sharyn I Katz, Despina Kontos and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Multiomic random forest toxicity modeling of radiation esophagitis.Physics and imaging in radiation oncology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

José Marcio LunaDepartment of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, United States.
Hann-Hsiang ChaoDepartment of Radiation Oncology, Hunter Holmes McGuire Veterans Affairs Medical Center, 1201 Broad Rock Blvd, Richmond, VA 23249, United States.
Russel T ShinoharaDepartment of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Dr, Philadelphia, PA 19104, United States.
Lyle H UngarDepartment of Computer and Information Science, University of Pennsylvania, 3330 Walnut St, Philadelphia, PA 19104, United States.
Keith A CengelDepartment of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, United States.
Daniel A PrymaDepartment of Radiology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, United States.
Chidambaram ChinniahAlbany Medical College, 43 New Scotland Ave, Albany, NY 12208, United States.
Abigail T BermanDepartment of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, United States.
Sharyn I KatzDepartment of Radiology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, United States.
Despina KontosDepartment of Radiology, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104, United States.
Charles B SimoneDepartment of Radiation Oncology, New York Proton Center, 225 East 126 St, New York, NY 10035, United States.
Eric S DiffenderferDepartment of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, United States.
University of Pennsylvania · USAlbany Medical Center Hospital · USHunter Holmes McGuire VA Medical Center · USNew York Proton Center · US

Funding

Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on ImmunotherapyR01CA264835 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KATZ, SHARYN, KONTOS, DESPINA · 2021 to 2025
$2.8M
NCI NIH HHS R01 CA264835
6 · The paper itself

Abstract

background and purposeRadiation esophagitis is a clinically important toxicity seen with treatment for locally-advanced non-small cell lung cancer. There is considerable disagreement among prior studies in identifying predictors of radiation esophagitis. We apply machine learning algorithms to identify factors contributing to the development of radiation esophagitis to uncover previously unidentified criteria and more robust dosimetric factors. MATERIALS AND

methodsWe used machine learning approaches to identify predictors of grade ≥ 3 radiation esophagitis in a cohort of 202 consecutive locally-advanced non-small cell lung cancer patients treated with definitive chemoradiation from 2008 to 2016. We evaluated 35 clinical features per patient grouped into risk factors, comorbidities, imaging, stage, histology, radiotherapy, chemotherapy and dosimetry. Univariate and multivariate analyses were performed using a panel of 11 machine learning algorithms combined with predictive power assessments.

resultsAll patients were treated to a median dose of 66.6 Gy at 1.8 Gy per fraction using photon (89.6%) and proton (10.4%) beam therapy, most often with concurrent chemotherapy (86.6%). 11.4% of patients developed grade ≥ 3 radiation esophagitis. On univariate analysis, no individual feature was found to predict radiation esophagitis (AUC range 0.45-0.55, p ≥ 0.07). In multivariate analysis, all machine learning algorithms exhibited poor predictive performance (AUC range 0.46-0.56, p ≥ 0.07).

conclusionsContemporary machine learning algorithms applied to our modern, relatively large institutional cohort could not identify any reliable predictors of grade ≥ 3 radiation esophagitis. Additional patients are needed, and novel patient-specific and treatment characteristics should be investigated to develop clinically meaningful methods to mitigate this survival altering toxicity.

Indexed as

ChemoradiationIntensity-modulated radiation therapyMachine learningNon-small cell lung cancerProton beam therapyRadiation esophagitisRadiation-induced toxicity

Identifiers

PMID32274426
PMCPMC7132156
OpenAlexW3013922958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.